Home » Health & Medicine, Pharmaceuticals & Biotech » Global Uveitis Treatment Market is Expected to Expand at a CAGR of 7.3% from 2014 to 2020 by Persistence Market Research
“This report provides in-depth analysis and estimation of the uveitis treatment market for the period 2014–2020”
North America is the largest market and Asia the fastest growing market for uveitis treatment. In terms of the type of uveitis, anterior uveitis represents the largest growing segment of this market. Anterior uveitis refers to inflammation of the middle layer of the eye, which includes the iris and ciliary body.

According to a new market report published by Persistence Market Research “Global Market Study on Uveitis Treatment: Asia to Witness fastest Growth by 2020,” the global uveitis treatment market was valued at USD 539.0 million in 2014 and is expected to expand at a CAGR of 7.3% from 2014 to 2020, to reach USD 822.5 million by 2020.

Globally, the uveitis treatment market is witnessing significant growth due to increasing prevalence of uveitis and related complications. Moreover, rising aging population, increasing the prevalence of eye disorders, and growing government initiatives to reduce eye disorders are also driving the growth of the market. However, lack of awareness about eye disorders, poor primary healthcare infrastructure, and lack of health insurance in developing countries inhibits the growth of the market. The global uveitis treatment market is anticipated to grow from an estimated USD 539.0 million in 2014 to USD 822.5 million by 2020 at a CAGR of 7.3% during the forecast period.

Browse Full Report With TOC:
http://www.persistencemarketresearch.com/market-research/uveitis-treatment-market.asp

North America is the largest market and Asia the fastest growing market for uveitis treatment. In terms of the type of uveitis, anterior uveitis represents the largest growing segment of this market. Anterior uveitis refers to inflammation of the middle layer of the eye, which includes the iris and ciliary body. Anterior uveitis may be acute or chronic in nature. Anterior uveitis is caused mainly due to auto-immune disorders and bacterial, fungal, or viral infections. The anterior uveitis treatment market was estimated at USD 273.1 million in 2014 and is expected to reach USD 416.3 million by 2020, expanding at a CAGR of 7.3 % during the forecast period.

Some of the major players in the uveitis treatment market are pSivida Corp., XOMA Corporation, Alcon, Inc., Allergan, Inc., AbbVie Inc., Enzo Biochem Inc., OphthaliX Inc., Bausch & Lomb Incorporated, Regeneron Pharmaceuticals, Inc, and Santen Pharmaceutical Co., Ltd.

Request Sample Report:
http://www.persistencemarketresearch.com/samples/4430


About Us:

Persistence Market Research (PMR) is an innovative provider of market research reports and consulting services. The three PMR pillars of strength that have helped us win clients for years are: Quality Research, Quick Research, and In-depth Research.

PMR’s team of seasoned analysts and consultants are experts in their domain. At PMR, we process complex, exhaustive primary and secondary research data into valuable insight. We understand that each client has a unique problem statement, and address it with our strengths.

Media Contact
Company Name: Persistence Market Research PVT. LTD.
Contact Person: Glen Hare
Email: sales@persistencemarketresearch.com
Phone: +1-646-568-7751
Address:305 Broadway, 7th Floor
City: New York
State: NY
Country: United States
Website: http://www.persistencemarketresearch.com/

Comments are closed.